Abstract:Lipid nanoparticles (LNPs) are a type of lipid vesicles that possess a homogeneous lipid core. These vesicles are widely used in small-molecule drug and nucleic acid delivery and recently gained much attention because of their remarkable success as a delivery platform for COVID-19 mRNA vaccines. Nonetheless, the utility of transient protein expression induced by mRNA extends far beyond vaccines against infectious diseases─they also hold promise as cancer vaccines, protein replacement therapies, and gene editing components for rare genetic diseases. However, naked mRNA is inherently unstable and prone to rapid degradation by nucleases and self-hydrolysis. Encapsulation of mRNA within LNPs protects mRNA from extracellular ribonucleases and assists with intracellular mRNA delivery.In this Account, we discuss the core features of LNPs for RNA delivery. We focus our attention on LNPs designed to deliver mRNA; however, we also include examples of siRNA-LNP delivery where appropriate to highlight the commonalities and the dissimilarities due to the nucleic acid structure. First, we introduce the concept of LNPs, the advantages and disadvantages of utilizing nucleic acids as therapeutic agents, and the general reasoning behind the molecular makeup of LNPs. We also briefly highlight the most recent clinical successes of LNP-based nucleic acid therapies. Second, we describe the theory and methods of LNP self-assembly. The common idea behind all of the preparation methods is inducing electrostatic interactions between the nucleic acid and charged lipids and promoting nanoparticle growth via hydrophobic interactions. Third, we break down the LNP composition with special attention to the fundamental properties and purposes of each component. This includes the identified molecular design criteria, commercial sourcing, impact on intracellular trafficking, and contribution to the properties of LNPs. One of the key components of LNPs is ionizable lipids, which initiate electrostatic binding with endosomal membranes and facilitate cytosolic release; however, the roles of other lipid components should not be disregarded, as they are associated with stability, clearance, and distribution of LNPs. Fourth, we review the attributes of LNP constructs as a whole that can heavily influence RNA delivery. These attributes are LNP size, charge, internal structure, lipid packing, lipid membrane hydration, stability, and affinity toward biomacromolecules. We also discuss the specific techniques used to examine these attributes and how they can be adjusted. Finally, we offer our perspective on the future of RNA therapies and some questions that remain in the realm of LNP formulation and optimization.

Insights into the formulation of lipid nanoparticles for the optimization of mRNA therapeutics

An overview of lipid constituents in lipid nanoparticle mRNA delivery systems

Recent Advances in Lipid Nanoparticles for Delivery of mRNA

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Development and applications of mRNA treatment based on lipid nanoparticles

Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing

Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics

The optimization strategies of LNP-mRNA formulations: Development and challenges for further application

Chemistry of Lipid Nanoparticles for RNA Delivery

Lipid nanoparticles for mRNA delivery

Targeting and Therapeutic Aspects

Lipid Nanoparticles: Key Facilitators of mRNA Vaccine Development

Strategies for Organ-Targeted mRNA Delivery by Lipid Nanoparticles.

Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery

Optimization of phospholipid chemistry for improved lipid nanoparticle (LNP) delivery of messenger RNA (mRNA).

Advances in the study of LNPs for mRNA delivery and clinical applications

Lipid Nanoparticles─From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Current landscape of mRNA technologies and delivery systems for new modality therapeutics

Paracyclophane-based ionizable lipids for efficient mRNA delivery in vivo

Dual Ethanolamine Head Groups in Ionizable Lipids Facilitate Phospholipid-free Stable Nanoparticle Formulation for Augmented and Safer mRNA Delivery

The Immunostimulatory Nature of mRNA Lipid Nanoparticles